(Q33542332)

27 July 2017

1 reference

title

The Fas counterattack: cancer as a site of immune privilege (English)

1 reference

27 July 2017

O'Connell J

1

1 reference

27 July 2017

Bennett MW

2

1 reference

27 July 2017

O'Sullivan GC

3

1 reference

27 July 2017

Collins JK

4

1 reference

27 July 2017

Shanahan F

5

1 reference

27 July 2017

language of work or name

1 reference

1 January 1999

1 reference

27 July 2017

1 reference

27 July 2017

20

1 reference

27 July 2017

46-52

1 reference

27 July 2017

1

1 reference

Tumor antigens recognized by T lymphocytes

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

New tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Serological analysis of human tumor antigens: molecular definition and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Costimulation of T cells for tumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

A role for CD95 ligand in preventing graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

The role of FasL-induced apoptosis in immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Cell death and the immune response: a lesson from the privileged

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Fas involvement in cytotoxicity mediated by human NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Signals from lymphocytes in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Fas ligand in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Metalloproteinase-mediated release of human Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Downregulation of Fas ligand by shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Apoptosis of crypt epithelial cells in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Protease activation during apoptosis: death by a thousand cuts?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

CASH, a novel caspase homologue with death effector domains

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Casper is a FADD- and caspase-related inducer of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Placing death under control

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

FAP-1: a protein tyrosine phosphatase that associates with Fas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

The proto-oncogene Bcl-2 and its role in regulating apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Regulation of the Fas apoptotic cell death pathway by Abl.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

APOPTOSIS: A Myc-Induced Apoptosis Pathway Surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Polymorphism of murine Fas ligand that affects the biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Fas-ligand: privilege and peril

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

FasL--too much of a good thing? Transplanted grafts of pancreatic islet cells engineered to express Fas ligand are destroyed not protected by the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Antitumor effect of locally produced CD95 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Unraveling immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Human glioblastoma cell derived transforming growth factor-beta 2: evidence for secretion of both high and low molecular weight biologically active forms

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Biosynthesis and shedding of murine lymphoma gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Gangliosides and antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Expression and prognostic significance of immunoregulatory molecules in esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Expression of the co-stimulatory molecule B7 on melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

Thyroiditis and hepatitis: Fas on the road to disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901382-6

7 January 2021

10.1016/S0167-5699(98)01382-6

Identifiers

DOI

1 reference

27 July 2017

1 reference